表紙
市場調查報告書
商品編碼
797411

發熱性物質實驗的全球市場:2019年∼-2023年

Global Pyrogen Testing Market 2019-2023

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 118 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球發熱性物質測試市場,對治療各種疾病的生物醫藥品的需求提高。技術的進步和創新產品銷售促進市場成長,不過,動物管理領域的產品回收增加成為妨礙市場成長的主要原因之一。

本報告提供全球發熱性物質測試市場調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 報告的範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 各終端用戶比較:市場規模及預測(2018年∼2023年)
  • 製藥及生物科技企業
  • 醫療設備企業
  • 食品、飲料廠商
  • 市場機會:各終端用戶

第7章 客戶形勢

第8章 地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 成長要素與課題

  • 市場成長要素
  • 市場課題

第10章 市場趨勢

第11章 業者情勢

  • 概要
  • 創造性破壞狀況

第12章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Charles River
  • GenScript
  • Lonza
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

第13章 附錄

  • 調查方法
  • 簡稱的清單
目錄
Product Code: IRTNTR30844

About this market

Pharmaceutical and biotechnology companies, as well as research institutes, worldwide are increasingly focusing and spending on R&D for drug discovery and development due to the rising prevalence of chronic diseases. Such an increase in the number of projects fuels the demand for pyrogen testing products as these products are vital in analyzing and detecting the bacterial toxins in the raw materials used for the production of medicines. This further leads to the high-volume generation of pyrogen testing products by various manufacturers. Thus, an increase in R&D spending in the pharmaceutical industry results in the development of new drugs. Such benefits have resulted in increased outsourcing to meet the rising global demand for new drugs, which will drive the growth of the global pyrogen testing market during the forecast period. Technavio's analysts have predicted that the pyrogen testing market will register a CAGR of over 12% by 2023.

Market Overview

Growing preference for value-added services

Vendors in the global pyrogen testing market are increasingly focusing on providing additional software along with pyrogen testing systems to successfully integrate the results obtained using these systems into the existing laboratory workflow and to record data for use at a later stage for R&D studies. Data integration is the key factor here as the data generated by pyrogen testing products need to be collated with other exploratory data to generate actionable insights and progress toward informed decision-making.

Stringent regulatory policies

Manufacturers are affected by the stringent government regulations that control the manufacture, distribution, marketing, and sales of drugs and medical devices. The stringent regulations are expected to hinder the growth of the global pyrogen testing market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the pyrogen testing market during the 2019-2023, view our report.

Competitive Landscape

The pyrogen testing market appears to be fairly fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1. Preface
  • 2.2. Preface
  • 2.3. Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023
  • Medical devices companies - Market size and forecast 2018-2023
  • Food and beverage manufacturers - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Charles River
  • GenScript
  • Lonza
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Medical devices companies - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Medical devices companies - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Food and beverage manufacturers - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Food and beverage manufacturers - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by end-user
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Advantages of using software with pyrogen testing systems
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Charles River - Vendor overview
  • Exhibit 47: Charles River - Product segments
  • Exhibit 48: Charles River - Organizational developments
  • Exhibit 49: Charles River - Geographic focus
  • Exhibit 50: Charles River - Segment focus
  • Exhibit 51: Charles River - Key offerings
  • Exhibit 52: GenScript - Vendor overview
  • Exhibit 53: GenScript - Business segments
  • Exhibit 54: GenScript - Organizational developments
  • Exhibit 55: GenScript - Geographic focus
  • Exhibit 56: GenScript - Segment focus
  • Exhibit 57: GenScript - Key offerings
  • Exhibit 58: Lonza - Vendor overview
  • Exhibit 59: Lonza - Business segments
  • Exhibit 60: Lonza - Organizational developments
  • Exhibit 61: Lonza - Geographic focus
  • Exhibit 62: Lonza - Segment focus
  • Exhibit 63: Lonza - Key offerings
  • Exhibit 64: Merck KGaA - Vendor overview
  • Exhibit 65: Merck KGaA - Business segments
  • Exhibit 66: Merck KGaA - Organizational developments
  • Exhibit 67: Merck KGaA - Geographic focus
  • Exhibit 68: Merck KGaA - Segment focus
  • Exhibit 69: Merck KGaA - Key offerings
  • Exhibit 70: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 71: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 72: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 73: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 74: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 75: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 76: Validation techniques employed for market sizing